| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ceb2504c8d821ee1e5dd0861abee6d7d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2019-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56502afda6074d014d3454f15af92387
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d97ed13f09359e84d3e903fd38a091b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_352985d3a486a2c541d9f258885bc2b1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f09009e2daf3e574c7a26f3a86b907db |
| publicationDate |
2020-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2020138486-A1 |
| titleOfInvention |
Vegf-a/vegfr2 pathway dual inhibition treatment, and pharmaceutical composition used for same |
| abstract |
Provided is a novel treatment of blocking both ligands and receptors thereof with antibodies. Specifically, the administration of an anti-VEGFR2 antibody drug as well as an anti-VEGF antibody drug as concomitant drugs is also effective against tumours that do not respond to anti-VEGFR2 antibodies alone. |
| priorityDate |
2018-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |